A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study

BACKGROUND: Controversy still exists regarding whether alendronate (ALN) use increases the risk of esophageal cancer or breast cancer. METHODS: This paper explores the possible association between the use of oral ALN in osteoporosis patients and subsequent cancer risk using the National Health Insur...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wen-Yuan, Sun, Li-Min, Lin, Ming-Chia, Liang, Ji-An, Chang, Shih-Ni, Sung, Fung-Chang, Muo, Chih-Hsin, Kao, Chia-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534103/
https://www.ncbi.nlm.nih.gov/pubmed/23300854
http://dx.doi.org/10.1371/journal.pone.0053032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534103/
https://www.ncbi.nlm.nih.gov/pubmed/23300854
http://dx.doi.org/10.1371/journal.pone.0053032

Ejemplares similares